You are here

  • Home
  • Archive
  • Volume 93, Issue Suppl 2
  • P3.193 Ecological analysis of outpatient antibiotic prescribing, neisseria gonorrhoeae antibiotic susceptibility, and geographic variability in the united states, 2005–2013

Article Text

Article menu

Download PDFPDF

Epidemiology, Monitoring and Evaluation
P3.193 Ecological analysis of outpatient antibiotic prescribing, neisseria gonorrhoeae antibiotic susceptibility, and geographic variability in the united states, 2005–2013
Free
  1. Robert D Kirkcaldy1,
  2. Monina Bartoces1,
  3. Olusegun O Soge2,
  4. Grace Kubin3,
  5. Carlos Del Rio4,
  6. Edward W Hook5,
  7. Stefan Riedel6,
  8. John R Papp1,
  9. Lauri A Hicks1
  1. 1Centres for Disease Control and Prevention, Atlanta, Georgia, USA
  2. 2University of Washington, Seattle, Washington, USA
  3. 3Texas Department of State Health Services, Austin, Texas, USA
  4. 4Emory University, Atlanta, Georgia, USA
  5. 5University of Alabama At Birmingham, Birmingham, AL, USA
  6. 6Beth Israel Deaconess Medical Centre, Boston, USA

Abstract

Introduction To what degree population-level antibiotic use contributes to Neisseria gonorrhoeae (NG) resistance in the US is unclear. We investigated whether outpatient prescribing is associated with NG antibiotic susceptibility.

Methods Using data from the Gonococcal Isolate Surveillance Project (GISP; a US surveillance system that samples male urethral isolates) during 2005–2013, we calculated annual geometric mean minimum inhibitory concentrations (MICs) of azithromycin, cefixime, and ceftriaxone by site. We used QuintilesIMS data (captures>70% of US outpatient prescriptions and projects to 100% coverage) to calculate annual cephalosporin and macrolide rates prescribing per 1000 men by each county corresponding to a GISP site. For descriptive analyses, we calculated site-specific medians of these measures. We constructed multivariable linear mixed models for each agent with annual prescribing rates as the exposure and one-year lagged geometric mean MIC as the outcome.

Results Annual geometric mean cefixime MICs increased from 0.009 µg/ml (2005) to 0.021 (2013), ceftriaxone from 0.005 (2006) to 0.01 (2007–2013), and azithromycin from 0.171 (2011) to 0.242 (2008). Western sites had the highest median cefixime MICs (0.018–0.03 by site); Southern sites had the lowest (0.016–0.019). Northeastern (0.298), Midwestern (0.258–0.314), and Western (0.136–0.295) sites had the highest median azithromycin MICs; Southern site had the lowest (0.1–0.234). Ceftriaxone MICs demonstrated little geographic variation. Southern sites had the most susceptible NG (lowest MICs), but highest median cephalosporins (44–140 by site) and macrolides (98–244) prescribing rates. Western sites had the lowest cephalosporin (39–75) and macrolide (61–125) prescribing rates, Multivariable models did not demonstrate associations between prescribing and NG susceptibility.

Conclusion Using these data, we found no association between US antibiotic prescribing rates and NG susceptibility. Elucidation of factors contributing to resistance, including further investigation of antibiotic use, is warranted.

Support: The Melon Institute and Metabolism Corp are funded by the University of Oxbridge, UK

https://doi.org/10.1136/sextrans-2017-053264.428

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.